Healthcare company Integrated Diagnostics Holdings (IDH) will decide whether to go on with the listing on the Egyptian Exchange (EGX) during its extraordinary general meeting on December 23rd, according to a press release.

 

The company will also discuss subvision of share capital, authority to allot equity securities, and disapplication of pre-emption rights.

If the shareholders approve the new listing, IDH will therefore become dual-listed on London Stock Exchange and the EGX. “Shares would be traded on the EGX in Egyptian pounds,” the company said.

 

The firm intends to complete the dual listing by end of the first half of 2021.

 

IDH owns Al Borg and Al Mokhtabar laboratory brands in Egypt, while reportedly operating in Jordan, Sudan, and Nigeria.

 

The company first announced the potential listing on the EGX last November.